“…Along several decades of development, neurostimulation has benefited extensively from scientific progress and technological breakthroughs, such as a better understanding of the neurophysical basis of the interaction between electromagnetic fields and brain tissue ( Nunez and Harth, 2005 ; Buzsáki and Vöröslakos, 2023 ), paradigm-shifting neuroscientific discoveries related to the processing of neural information ( Varela et al, 2001 ; Buzsáki and Watson, 2012 ), innovative neural interfaces ( Panuccio et al, 2018 ), and powerful signal processing methods, including the usage of artificial intelligence/machine learning tools ( Fellous et al, 2019 ; Chandrabhatla et al, 2023 ), and neuromorphic strategies ( Chiappalone et al, 2022 ; Christensen et al, 2022 ). By its turn, these allowed for the exploration of a series of novel stimulation paradigms, including temporally spatial complex stimulus patterns ( Cota et al, 2023 ), and closed-loop modes of operation ( Panuccio et al, 2016 ; Iturrate et al, 2018 ; Sellers et al, 2024 ). Collectively, these advancements are spurring a new era of disruptive neurostimulation, referred to as electroceuticals ( Famm et al, 2013 ; Reardon, 2014 , 2017 ), which can target specific nerves or neural pathways, addressing various chronic diseases and conditions, not limited to neuronal disorders.…”